Rozlytrek Drug Interactions: 195 Major, 886 Moderate
Rozlytrek (Entrectinib) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Rozlytrek. Always confirm against the full prescribing information.
100 interactions
Abacavir
The risk or severity of liver damage can be increased when Abacavir is combined with Entrectinib.
Level 2 evidence
Abiraterone
The risk or severity of liver damage can be increased when Abiraterone is combined with Entrectinib.
Level 2 evidence
Acalabrutinib
The metabolism of Entrectinib can be decreased when combined with Acalabrutinib.
Level 2 evidence
Acamprosate
The risk or severity of liver damage can be increased when Acamprosate is combined with Entrectinib.
Level 2 evidence
Acarbose
The risk or severity of liver damage can be increased when Acarbose is combined with Entrectinib.
Level 2 evidence
Acebutolol
The risk or severity of QTc prolongation can be increased when Acebutolol is combined with Entrectinib.
Level 1 evidence
Aceclofenac
The risk or severity of liver damage can be increased when Aceclofenac is combined with Entrectinib.
Level 2 evidence
Acetazolamide
The metabolism of Entrectinib can be decreased when combined with Acetazolamide.
Level 2 evidence
Acetohydroxamic acid
The risk or severity of liver damage can be increased when Acetohydroxamic acid is combined with Entrectinib.
Level 2 evidence
Acetylsalicylic acid
The risk or severity of liver damage can be increased when Acetylsalicylic acid is combined with Entrectinib.
Level 2 evidence
Acitretin
The risk or severity of liver damage can be increased when Acitretin is combined with Entrectinib.
Level 2 evidence
Acrivastine
The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Entrectinib.
Level 1 evidence
Enter your NPI to unlock 14 major interactions for Rozlytrek
Rozlytrek (Entrectinib) has 1100 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Rozlytrek (Entrectinib) has 195 major, 886 moderate, and 19 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Rozlytrek. Always confirm against the full prescribing information.